These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 286125)

  • 41. Influence of growth state on several thermal responses of EMT6/Az tumor cells in vitro.
    Gerner EW; Holmes PW; McCullough JA
    Cancer Res; 1979 Mar; 39(3):981-6. PubMed ID: 427784
    [No Abstract]   [Full Text] [Related]  

  • 42. Antitumor activity of Propionibacterium acnes (Corynebacterium parvum) and isolated cytoplasmic fractions.
    Millman I; Scott AW; Halbherr T
    Cancer Res; 1977 Nov; 37(11):4150-5. PubMed ID: 409491
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Passive transfer of "Corynebacterium parvum" anti-tumour protection by stimulated peritoneal cells ].
    Mazurek C; Stiffel C; Chalvet H; Biozzi G
    Ann Immunol (Paris); 1981; 132D(1):43-54. PubMed ID: 6896973
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effect of Corynebacterium parvum on the response to irradiation of a C3H fibrosarcoma.
    Suit HD; Sedlacek R; Wagner M; Orsi L; Silobrcic V; Rothman KJ
    Cancer Res; 1976 Apr; 36(4):1305-14. PubMed ID: 1260756
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effect of C. parvum on intratumor immunity to the T1699 mammary adenocarcinoma.
    Haskill S; Ritter F; Becker S
    J Immunol; 1980 Jul; 125(1):454-8. PubMed ID: 6247400
    [No Abstract]   [Full Text] [Related]  

  • 46. [Antitumor effect of Corynebacterium parvum on C3H mouse bearing MH-134 tumor].
    Nakamura K; Miwa H; Hashimoto O; Inoue T; Orita K
    Gan To Kagaku Ryoho; 1982 Jul; 9(6):1046-51. PubMed ID: 7184438
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Requirements for successful immunotherapy and chemoimmunotherapy of a murine model of ovarian cancer.
    Vanhaelen CP; Fisher RI
    Cancer Res; 1981 Mar; 41(3):980-3. PubMed ID: 7193085
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Antitumor activity of killed Corynebacterium parvum suspensions in a murine mammary adenocarcinoma CaD2) system.
    Purnell DM; Otterstrom JR; Bartlett GL; Kreider JW
    J Natl Cancer Inst; 1976 Jun; 56(6):1171-5. PubMed ID: 994219
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The distribution and persistence in vivo of Corynebacterium parvum in relation to its antitumor activity.
    Scott MT; Milas L
    Cancer Res; 1977 Jun; 37(6):1673-9. PubMed ID: 870181
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Organ distribution of technetium-99m-labeled corynebacterium parvum in normal and tumor-bearing mice.
    Barth RF; Singla O
    Cancer Res; 1978 Jan; 38(1):32-4. PubMed ID: 618580
    [No Abstract]   [Full Text] [Related]  

  • 51. The immunological activities of components isolated from Corynebacterium parvum in mice injected with polyoma tumor cells.
    Tomecki J; Mara M
    Neoplasma; 1987; 34(1):15-22. PubMed ID: 3031518
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Equipotent generation of protective antitumor immunity by various methods of dendritic cell loading with whole cell tumor antigens.
    Lambert LA; Gibson GR; Maloney M; Barth RJ
    J Immunother; 2001; 24(3):232-6. PubMed ID: 11394500
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effect of adriamycin and Corynebacterium parvum in tumor-bearing mice: modulation of response to sheep red blood cells.
    Dimitrov NV; Denny TN; Weisman MF; Cameron DG
    J Natl Cancer Inst; 1979 Aug; 63(2):423-6. PubMed ID: 379400
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Further observations on the inhibition of tumor growth by Corynebacterium parvum with cyclophosphamide. I. Variation in administration of both agents.
    Fisher B; Wolmark N; Rubin H; Saffer E
    J Natl Cancer Inst; 1975 Nov; 55(5):1147-53. PubMed ID: 1206740
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Proceedings: The effect of Bacille Calmette-Guérin (BCG) and Corynebacterium parvum on the development of spontaneous mouse mammary carcinoma.
    Simpson JS; Clark AW
    Br J Surg; 1976 Feb; 63(2):152-3. PubMed ID: 766891
    [No Abstract]   [Full Text] [Related]  

  • 56. The effect of nonspecific immune stimulation with Corynebacterium parvum and polidin on the Ehrlich ascites tumor growth.
    Todoruţiu C; Rişcă R; Daicoviciu D; Mulea R
    Morphol Embryol (Bucur); 1982; 28(1):77-83. PubMed ID: 6461826
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Modification of radiation responses of murine tumors by misonidazole (Ro 07-0582), host immune capability, and Corynebacterium parvum.
    Stone HB; Milas L
    J Natl Cancer Inst; 1978 Apr; 60(4):887-93. PubMed ID: 633396
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Fc receptor-bearing and phagocytic cells in syngeneic tumours of C. parvum- and carrageenan-treated mice.
    Thomson AW; Cruickshank N; Fowler EF
    Br J Cancer; 1979 May; 39(5):598-602. PubMed ID: 486317
    [No Abstract]   [Full Text] [Related]  

  • 59. Radiation therapy and Corynebacterium parvum in the treatment of murine tumors.
    Suit HD; Sedlacek RS; Silobrcic V; Linggood RM
    Cancer; 1976 Jun; 37(6):2573-9. PubMed ID: 949676
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Combined radiotherapy and Corynebacterium parvum treatment of rat tumors with different immunogenicity.
    Moroson H; Stowe S; Rotman M; Schechter M
    Int J Radiat Oncol Biol Phys; 1978; 4(7-8):649-55. PubMed ID: 711536
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.